Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Laura Rozenblum, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Rozenblum L, Zaragori T, Tran S, Morales-Martinez A, Taillandier L, Blonski M, Rech F, Galanaud D, Kas A, Verger A. Differentiating high-grade glioma progression from treatment-related changes with dynamic [18F]FDOPA PET: a multicentric study. Eur Radiol. 2022 Nov 11. PMID: 36367578.
    Citations:    Fields:    
  2. Soret M, Maisonobe JA, Desarnaud S, Bergeret S, Causse-Lemercier V, Berenbaum A, Rozenblum L, Habert MO, Kas A. Ultra-low-dose in brain 18F-FDG PET/MRI in clinical settings. Sci Rep. 2022 09 12; 12(1):15341. PMID: 36097015; PMCID: PMC9467977.
    Citations:    Fields:    Translation:Humans
  3. Rozenblum L, Houillier C, Soussain C, Bertaux M, Choquet S, Galanaud D, Hoang-Xuan K, Kas A. Role of Positron Emission Tomography in Primary Central Nervous System Lymphoma. Cancers (Basel). 2022 Aug 23; 14(17). PMID: 36077613; PMCID: PMC9454946.
  4. Bertaux M, Berenbaum A, Di Stefano AL, Rozenblum L, Soret M, Bergeret S, Hoang-Xuan K, Tainturier LE, Sgard B, Habert MO, Delattre JY, Dehais C, Idbaih A, Pyatigorskaya N, Kas A. Hybrid [18F]-F-DOPA PET/MRI Interpretation Criteria and Scores for Glioma Follow-up After Radiotherapy. Clin Neuroradiol. 2022 Sep; 32(3):735-747. PMID: 35147721.
    Citations: 1     Fields:    Translation:Humans
  5. Ahrari S, Zaragori T, Rozenblum L, Oster J, Imbert L, Kas A, Verger A. Relevance of Dynamic 18F-DOPA PET Radiomics for Differentiation of High-Grade Glioma Progression from Treatment-Related Changes. Biomedicines. 2021 Dec 16; 9(12). PMID: 34944740; PMCID: PMC8698938.
    Citations: 2     
  6. Partouche E, Yeh R, Eche T, Rozenblum L, Carrere N, Guimbaud R, Dierickx LO, Rousseau H, Dercle L, Mokrane FZ. Updated Trends in Imaging Practices for Pancreatic Neuroendocrine Tumors (PNETs): A Systematic Review and Meta-Analysis to Pave the Way for Standardization in the New Era of Big Data and Artificial Intelligence. Front Oncol. 2021; 11:628408. PMID: 34336643; PMCID: PMC8316992.
    Citations: 2     
  7. Pyatigorskaya N, Habert MO, Rozenblum L. Contribution of PET-MRI in brain diseases in clinical practice. Curr Opin Neurol. 2020 08; 33(4):430-438. PMID: 32657884.
    Citations: 2     Fields:    Translation:Humans
  8. Vavasseur A, Muscari F, Meyrignac O, Nodot M, Dedouit F, Revel-Mouroz P, Dercle L, Rozenblum L, Wang L, Maulat C, Rousseau H, Otal P, Dercle L, Mokrane FZ. Blended learning of radiology improves medical students' performance, satisfaction, and engagement. Insights Imaging. 2020 Apr 28; 11(1):61. PMID: 32347421; PMCID: PMC7188751.
    Citations: 8     
  9. Rozenblum L, Bertaux M, Bielle F, Ollivier M, Choquet S, Garcilazo Y, Mokhtari K, Kas A. 18F-FDOPA PET/CT Findings in a Patient With Primary Cerebral Amyloidoma. Clin Nucl Med. 2020 Apr; 45(4):e206-e207. PMID: 32049735.
    Citations:    Fields:    Translation:Humans
  10. Rozenblum L, Mokrane FZ, Yeh R, Sinigaglia M, Besson FL, Seban RD, Zadro C, Dierickx L, Chougnet CN, Partouche E, Revel-Mouroz P, Zhao B, Otal P, Schwartz LH, Dercle L. Imaging-guided precision medicine in non-resectable gastro-entero-pancreatic neuroendocrine tumors: A step-by-step approach. Eur J Radiol. 2020 Jan; 122:108743. PMID: 31783345.
    Citations: 4     Fields:    Translation:Humans
  11. Rozenblum L, Mokrane FZ, Yeh R, Sinigaglia M, Besson F, Seban RD, Chougnet CN, Revel-Mouroz P, Zhao B, Otal P, Schwartz LH, Dercle L. The role of multimodal imaging in guiding resectability and cytoreduction in pancreatic neuroendocrine tumors: focus on PET and MRI. Abdom Radiol (NY). 2019 07; 44(7):2474-2493. PMID: 30980115.
    Citations: 4     Fields:    Translation:Humans
  12. Rozenblum L, Habert MO, Pyatigorskaya N, Roue-Jagot C, Kas A. FDG PET/MRI Findings Pointing Toward a Gayet-Wernicke Encephalopathy. Clin Nucl Med. 2019 Jul; 44(7):e456-e457. PMID: 31058688.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Rozenblum's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (30)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.